Background: During the past 20 years, significant advances in patient care have resulted in individuals with spinal cord injury (SCI) living longer than before. As lifespan increases, cardiovascular complications are emerging as the leading cause of mortality in this population, and individuals with SCI develop cardiovascular disease at younger ages than their able-bodied counterparts. To address this increasing clinical challenge, several recent studies investigated the central cardiovascular adaptations that occur following SCI. However, a somewhat less recognized component of cardiovascular dysfunction in this population is the peripheral vascular adaptations that also occur as a result of SCI. Study design: Literature review.
INTRODUCTION
A spinal cord injury (SCI) is among the most devastating and debilitating conditions an individual can sustain. The most recent estimates of SCI incidence in the United States vary from 25 to 59 new cases per million inhabitants per year, with an average of 40 per million. 1 In addition to severe motor and sensory dysfunction, SCI also disrupts autonomic pathways 2 and consequently perturbs cardiovascular homeostasis. Cardiovascular complications in the early stages of high SCI can be life-threatening, and include profound hypotension, bradyarrhythmias and cardiac arrest. 3 There is also alarming recent evidence demonstrating an increased risk of ischemic stroke after SCI. 4 Although some of these complications can improve in the weeks following SCI, cardiovascular control rarely returns to pre-injury baseline.
Individuals with SCI are at increased risk for cardiovascular disease (CVD) compared with their able-bodied (AB) counterparts; 5 however, the factors that contribute to the elevated risk in this population are not well understood. CVD risk prediction is typically based on factors such as sex, age, diabetes, blood lipid profile, elevated systolic blood pressure and smoking status. 6 These 'traditional' risk factors, however, do not fully explain the increased CVD risk in individuals with SCI. 7 For instance, people with high-thoracic/cervical SCI exhibit autonomic disturbances that result in a low resting arterial blood pressure 8 -something that is usually considered cardioprotective-yet they exhibit a greater prevalence of CVD than the AB population. Thus, other factors must at least partly be responsible for the elevated CVD risk in the SCI population, and recent evidence suggests that there is a need for more specific recommendations for the management of CVD in the SCI population. 9 In the AB population, studies that have investigated the reduction in CVD risk with exercise have reported that only 40-60% of the risk reduction is explained by improvements in traditional CVD risk factors. 10 It has been postulated that exercise-induced improvements in endothelial function may be responsible for this 'risk factor gap' . 11, 12 To our knowledge, dysfunction of the peripheral vasculature as a contributor to CVD in the SCI population has not been investigated. Indeed, most studies describing cardiovascular changes after SCI have focused on central cardiovascular adaptations. [13] [14] [15] This is somewhat surprising: as we will describe in this review, SCI induces vascular deconditioning below the level of injury and disrupts supraspinal control of the spinal sympathetic circuits that ultimately innervate the adventitial-media layer of blood vessels, both of which lead to a multitude of vascular abnormalities that may contribute to elevated CVD risk. 16 It is highly likely, therefore, that adaptations in the peripheral vasculature after SCI are of equal, if not greater, clinical importance than the wellrecognized central cardiovascular adaptations that occur in this population. Accordingly, the aim of this review is threefold: (1) to provide an overview of the autonomic nervous system and blood vessel structure and function; (2) to describe changes thereof following SCI; and (3) to discuss the effects that loss of sympathetic neural control and physical deconditioning has on the peripheral vasculature in the SCI population.
METHODS
A systematic review of the literature to extract studies that incorporated measures of arterial structure or function after SCI in animals or humans was conducted using the following online databases: MED-LINE, EMBASE and SPORTDiscus. Population search terms included: spinal cord injury, paraplegia, tetraplegia and quadriplegia. Vascular keywords included: arterial, vasculature, peripheral, cardiovascular, sympathetic, parasympathetic, vascular stiffness, vascular compliance, adrenoceptor, hyper-responsiveness, shear stress, shear rate, hypertension, blood pressure, autonomic dysreflexia (AD), endothelial, leg blood flow, femoral and carotid. Exercise keywords included: functional electrical stimulation (FES), cycling, treadmill, wheelchair, body-weight-supported treadmill training, passive and resistance. Abstracts were reviewed to identify relevant studies, and where the relevant information was not available in the abstract, the Methods section was also reviewed. All studies published in English that incorporated measures of arterial structure or function at rest or in response to an intervention in humans or animals with SCI were included. A total of 36 studies were included in the review. For the purpose of this review, we use the term 'peripheral' to denote blood vessels outside of the central nervous system (brain and spinal cord).
ORGANIZATION OF THE AUTONOMIC NERVOUS SYSTEM
The autonomic nervous system is divided into two primary components: sympathetic and parasympathetic. The sympathetic nervous system (SNS) is considered 'excitatory' , whereas the parasympathetic nervous system (PNS) is 'suppressive'; collectively, these systems provide balanced autonomic control. Both divisions of the autonomic nervous system innervate the majority of visceral organs, including the heart. 2 Exceptions to this rule are the majority of blood vessels, which receive only sympathetic innervations, and the cavernous tissue of the penis and clitoris, which receive only parasympathetic innervations. However, there is also evidence that the cerebral and pulmonary blood vessels also have parasympathetic innervations. 17 Finally, peptidergic, purinergic and nitrigic sensory fibers also innervate all blood vessels and cavernous tissues. Despite functional differences, the organization of the SNS and parasympathetic nervous system share some similarities. For example, both divisions of the autonomic nervous system have two neuronal populations. The first neuronal population is the preganglionic neurons, whose cell body is in the gray matter of the brain or spinal cord. Sympathetic and parasympathetic preganglionic neurons are cholinergic and release the neurotransmitter acetylcholine. Preganglionic nerves travel in the anterior roots of the spinal cord or cranial nerves and synapse on the second population of neurons, the postganglionic neurons, which are located in the autonomic ganglia of the peripheral nervous system. 18 The axons of the postganglionic neurons then synapse with the target organs.
Preganglionic neurons of the SNS originate in the spinal gray matter in the thoracic (T1-T12) and upper lumbar segments of the spine (L1-L2). Axons of the sympathetic preganglionic neurons exit through the anterior roots of the spinal cord and synapse onto postganglionic sympathetic neurons in the sympathetic chain ganglia and prevertebral ganglia. Sympathetic postganglionic fibers are longer than those of the cholinergic nervous system and are mostly adrenergic, releasing the neurotransmitter norepinephrine (NE); an exception is the sympathetic fibers innervating sweat glands and piloerector muscles, which release acetylcholine. The segmental sympathetic innervations that are particularly important for understanding cardiovascular control in individuals with SCI are the sympathetic innervation of the heart at T1-T4, the blood vessels of the upper limbs at T1-T4 and the blood vessels of the splanchnic bed and lower limbs at T6-L2 (Figure 1) .
Preganglionic neurons of the parasympathetic nervous system originate within four cranial nerves (CN III, VII, IX and X) of the brainstem and within the sacral spinal segments (S2-S4). 2, 19 In contrast to the SNS, there is no parasympathetic innervation of the peripheral vasculature. The heart and pulmonary tree, however, are under parasympathetic control through the vagus nerve (CN X), a cranial nerve that exits the brainstem and synapses with the sinoatrial node and the nerve cells in the enteric nervous system; hence, the upper portion of the gastrointestinal tract also receives parasympathetic innervation. 19 CARDIOVASCULAR CONTROL AFTER SCI Following SCI there is loss or decrease of the central sympathetic tone (neurogenic-originates from supraspinal neuronal centers). Although peripheral tone (myogenic-originates from smooth muscle of the blood vessels) is preserved, it is inadequate at maintaining arterial blood pressure following high thoracic or cervical SCI. Consequently, the acute period after SCI is characterized by profound hypotension, and pharmacological intervention via vasopressive therapy may be required to maintain arterial blood pressure during this period. 20, 21 Of particular importance in the development of hypotension is the loss of sympathetic tonic activity to a significant portion of the peripheral blood vessels below the lesion; hence, those with the highest (cervical) injuries exhibit the most severe hypotension. 8 In addition to resting hypotension, most individuals with high SCI experience orthostatic hypotension when transferring from a supine to a seated position. [22] [23] [24] [25] [26] In the AB population, it is well known that on assumption of the upright posture, there is a baroreflex-mediated peripheral vasoconstriction via an increased sympathetic outflow to maintain blood pressure and cerebral perfusion. 27, 28 It is, therefore, likely that both sympathetic hypoactivity and altered baroreceptor sensitivity are the primary causes of orthostatic hypotension following cervical SCI. 29, 30 However, a lack of skeletal muscle pump, 31 cardiovascular deconditioning 32 and/or altered salt and water balance 33 have also been hypothesized to contribute to hypotension.
Initially, in the acute period of SCI both individuals with tetraplegia and paraplegia present with significant orthostatic hypotension. 34 With time post injury, however, it has been demonstrated that individuals with thoracic SCI exhibit an increase in leg vascular resistance during head-up tilt that is consistent with that in the AB population. [35] [36] [37] The increase in leg vascular resistance was attributed to a local myogenic response triggered by changes in vascular pressure changes during head-up tilt. 35 It should be noted, however, that those studies [35] [36] [37] were all delimited to paraplegics with injuries between T4 and L1, some of whom would be expected to retain partial-to-full supraspinal sympathetic control of the critical splanchnic bed, which may explain the reduced severity of orthostatic hypotension in those studies. It is highly likely that paraplegics with an injury at or above T6, who exhibit no remaining supraspinal sympathetic control of the splanchnic bed, would exhibit marked orthostatic hypotension; however, this postulate remains to be tested. Finally, it is also important to note that none of the studies, which investigated severity of orthostatic hypotension, confirmed autonomic completeness of injury. We have previously shown autonomic completeness of injury to be one of the most important determinants of cardiovascular function. 38 Further to persistent hypotension, patients with SCI above T6 regularly experience life-threatening episodic bouts of extreme hypertension (up to a systolic blood pressure of 300 mm Hg) that is accompanied by pronounced bradycardia, a disorder known as AD. 39 During AD, both noxious and non-noxious stimuli below the lesion, such as bowel or bladder distension, could cause exaggerated activation of the spinal circuits caudal to the injury that project to the sympathetic pre-ganglionic neurons. In turn, this usually triggers a sympathetically mediated peripheral vasoconstriction in the gut, muscle and skin vascular beds, causing extreme systemic hypertension. 25, 40 Finally, a parasympathetic-induced bradycardia could be present during episodes of AD as a baroreflex-mediated response to the hypertension. 25 Episodes of AD are commonly accompanied by pounding headaches and upper-body flushing, while below the lesion there is pale and cold skin due to significant vasoconstriction. If left untreated, AD can cause serious complications, including intracranial hemorrhage, myocardial infarction, retinal detachments, seizures and even death. [41] [42] [43] [44] Although there is still no consensus on the exact pathophysiology explaining AD, it is generally accepted that loss of supraspinal input to the spinal sympathetic circuits, reduced overall sympathetic activity, disruption of spinal reflexes and plastic changes in the spinal cord and peripheral autonomic circuits all contribute to the development of AD. 2 In addition to the debilitating consequences of AD noted above, it is also possible that such repetitive and significant blood pressure elevations could induce a shear injury to the blood vessel endothelium, predisposing these individuals to cardiovascular complications in the future. 45 BLOOD VESSEL STRUCTURE AND CONTROL As blood transcends from the heart to the tissue, it moves from large elastic arteries, through muscular arteries and arterioles into thinwalled capillaries, where nutrient and gas exchange occurs. The arteries and arterioles are composed of three main layers, tunica intima, tunica media and tunica adventitia ( Figure 2 ). The tunica intima consists of a single layer of endothelial cells, which are conjoined to the arterial wall by a narrow layer of connective tissue; the tunica media is formed of bundles of smooth muscle cells intermingled with elastic fibers, and the tunica adventitia is formed of irregularly shaped collagen fibers. Although arteries and arterioles have the same global structure, each type of vessel has a specific structure that reflects the primary function of the vessel. For example, large conduit arteries have a thicker media (more smooth muscle cells), while in the tunica adventitia, there is increased collagen and elastin; these structural adaptations enable conduit vessels to produce the Windkessel effect of maintaining constant pressure despite the pulsatile blood flow. On the other hand, arterioles provide the major site of resistance to blood flow and are thus composed of a just a few layers of smooth muscle in the vessel wall. It is the arterioles that are also responsible for slowing blood flow to ensure adequate time for gas and nutrient exchange within the capillaries; consequently, the arterioles form the primary site for vascular resistance and are, therefore, of primary importance in the regulation of blood pressure.
All arterioles exhibit a state of partial constriction at rest that is termed myogenic tone. The degree of myogenic tone is determined by both intrinsic and extrinsic factors. Intrinsic factors include: endothelial factors, local chemical substances and hormones, metabolic by-products or hypoxia, and the myogenic response triggered by changes in intravascular pressure (Figure 2 ). Although the specific molecules involved in the myogenic response of arterioles is still far from understood, it is generally accepted that the smooth muscle membrane potential depolarizes to increase Ca 2 þ influx and triggers interaction of actin and myosin through changes in their relative regulatory enzymes. 46, 47 Further to intrinsic factors, there are also extrinsic neural and hormonal factors that affect arteriolar diameter, of which the SNS is the most important in the peripheral circulation. Sympathetic nerve fibers innervate all arteriolar smooth muscles, and NE released from such nerve endings acts via a-adrenoceptors to cause vasoconstriction. Other hormones that are primarily responsible for extrinsically influencing arteriolar diameter are nitric oxide, endothelin, vasopressin and angiotensin. The structure and control of blood vessels is summarized in Figure 2 .
CONDUIT ARTERIAL FUNCTION AFTER SCI Structural adaptations
It is well known that the vasculature responds to acute and chronic stimuli. Acute alterations are mediated primarily by changes in sympathetic activity to the smooth muscle, whereas chronic changes are mediated primarily by changes in blood flow and pressure, which alters shear stress and consequently the number of smooth muscle cells in vessel walls. 48 Remodeling of peripheral arteries in paralyzed limbs occurs soon after SCI; within weeks there is a significant reduction in systemic blood volume 49 and a consequent inward remodeling of the arterial wall, 50 such that the diameter of the common femoral artery is 30-50% smaller [51] [52] [53] [54] and resting blood flow in the leg is 30-40% lower than in AB individuals. 54, 55 Compared with the inactive lower limbs, the active upper limb vasculature is relatively well preserved. For example, the diameters of the common carotid artery 51, 53 and brachial artery 50 are similar between SCI and AB. Thus, it appears the structural adaptations below the injury are primarily an adaptation to the reduced metabolic demands of the lower limb vasculature. Indeed, in the only study to account for the reduced metabolic demand by correcting common femoral artery diameter for leg muscle volume, it was reported that femoral artery diameter and peak femoral blood flow after leg occlusion were not different between SCI and AB participants. 56 Further to the adaptations that occur in the first 6 weeks after injury, there is evidence to suggest that chronic stiffening of the arterial system also occurs after SCI. 57, 58 This is particularly worrying given that arterial stiffening is a significant independent risk factor for the development of CVD in the AB population. 59 Functional adaptations Shear stress. Shear stress is described as the frictional force of blood against the endothelium, and is equal to the local blood viscosity multiplied by local wall shear rate (which is calculated by dividing the velocity of blood flow by lumen radius). Shear stress is considered to be a key regulator of endothelial function, which in turn is independently linked to CVD. 60 Arteries respond to chronic changes in blood flow by altering their internal diameter such that changes in shear stress are minimized. However, shear stress and shear rate in the common femoral artery in individuals with SCI are Peripheral vascular function in spinal cord injury CR West et al 50-100% greater than in AB individuals. 51, 53, 54 The almost doubled shear rate appears to be a consequence of the inactivity rather than loss of supraspinal sympathetic control, as both tetraplegics (decreased sympathetic tone to a nearly all of the vasculature) and low paraplegics (decreased sympathetic tone to approximately half of the vasculature) demonstrate similar increases in shear stress compared with AB controls. 51 It should be noted that shear stress is inversely proportional to arterial diameter cubed at constant flow and viscosity. Thus, it has been postulated that inactivity increases shear rate via a reduction in femoral diameter and a consequent increase in velocity. 61 Endothelial function. The vascular endothelium is a single layer of cells that maintains anticoagulation properties, inhibits smooth muscle proliferation, modulates vascular permeability and enables fine control of the vascular diameter. The most commonly used method to assess endothelial function in humans is flow-mediated dilatation (FMD), which measures the ability of the blood vessels to accommodate increases in flow by altering their internal diameter, and is dependent on nitric oxide (NO) release by endothelial cells. 62 Several studies document a direct independent relationship between the risk for cardiovascular events and the degree of brachial FMD in non-SCI individuals, [63] [64] [65] whereby the degree of cardiovascular risk is increased as the degree of brachial FMD is reduced.
In individuals with SCI, FMD has been examined in the superficial femoral artery (SFA), 62, 66, 67 the posterior tibial artery, 68 brachial artery 67 and the radial artery. 68 In the SFA, individuals with SCI exhibit an increased absolute FMD compared with AB individuals; 69 however, this difference is no longer present when the degree of FMD is corrected for area under the shear rate curve, from the time of occluding cuff deflation to that of peak diameter attainment. 62 Such correction for the eliciting shear stress stimulus on the endothelial cell membrane is considered critical, especially in cases where arteries are compared with different baseline diameters (for example, SCI vs control). 61 In the only study to investigate brachial artery FMD, it was reported that absolute brachial artery FMD is not different between SCI and AB individuals, whereas brachial artery FMD expressed relative to the shear rate stimulus (in this case the change in shear rate ratio from rest to peak hyperemic response) was reduced in SCI compared with AB. 67 Enhanced or preserved FMD below the lesion and a reduction in FMD above the lesion appears counterintuitive given the known positive relationship between the degree of physical activity and FMD in AB. [70] [71] [72] Such differences in FMD above and below the lesion may be attributed to the structural adaptations that occur following SCI. Indeed, there is an inverse relationship between vessel size and the relative FMD. 73, 74 Thus a smaller deconditioned SFA may be expected to exhibit enhanced FMD, whereas an enlarged brachial artery may be expected to exhibit a reduced FMD. Unfortunately, the only study directly to test this postulate by examining differences in FMD above and below the lesion in similar-sized arteries reported that SCI individuals exhibit a similar reduction in FMD above and below the injury, suggesting that differences in baseline diameter do not fully explain the differences in FMD. 68 However, because of technical difficulties with the measurement of hyperemic blood flow velocity in the lower limb, this study was limited by the non-correction of FMD for shear rate in the lower limbs. Thus, future studies are required to confirm whether changes in baseline diameter explain the preserved or enhanced FMD below the lesion in SCI. Alternative explanations for an enhanced FMD below the lesion may be explained by chronic elevations in shear stress and a subsequent heightened sensitivity of NO/augmented expression of nitric oxide synthase in vascular smooth muscle, 75 although this appears unlikely since intra-arterial infusions of sodium nitroprusside (an NO donor) results in a similar degree of SFA vasodilatation in SCI and AB individuals. 66 Taken together, these findings suggest that FMD is enhanced or at least preserved below the lesion after SCI. Unfortunately, changes in arterial structure and shear stress complicate and hinder our quest to attribute such changes to a particular mechanism. To date, the literature has also assumed that FMD responses should be interpreted in the same way in SCI individuals as it is in AB. Indeed, no study has examined the relationship between the degree of FMD and risk for CVD in the SCI population, and no study has validated the use of FMD as an indicator of endothelial function in deconditioned limbs. Until such studies are carried out, the functional importance of the FMD findings remains to be determined.
RESISTANCE ARTERIES Structural adaptations
There is very little data regarding remodeling of the resistance arteries following SCI, which is surprising given that the resistance vessels are crucial to blood pressure regulation. Furthermore, individuals with SCI experience dramatic alterations in blood pressure control; thus, one may hypothesize that the degree of vascular remodeling may be exacerbated in such resistance vessels. Structural adaptations in resistance vessels are most commonly assessed by measuring the maximal hyperemic responses to limb ischemia. [76] [77] [78] This technique, which has been common place since the late 1950s, is based on the assumption that peak-reactive hyperemia in response to ischemia is limited by maximal cross-sectional area of the resistance vessel. More recently, there is evidence to suggest that that hyperemic blood flow responses in such vessels hold true prognostic value for predicting future cardiovascular events. 79, 80 In the only study to investigate resistance artery remodeling in SCI, individuals with chronic SCI exhibited a 40-60% reduction in SFA-reactive hyperemia compared with AB individuals. 67 This far exceeds values that occur in healthy AB individuals who undergo acute 81 or chronic 82 bed rest. Remodeling of resistance arteries appears to be at least partly attributable to general muscle atrophy, as lower-limb-reactive hyperemia corrected per unit muscle volume is similar between SCI and AB. 56 
Functional adaptations
Physiologically, it is reasonable to assume that loss of supraspinal sympathetic control will induce maximal dilatation in the peripheral arteries and a consequent reduction in peripheral vascular resistance. The most accessible peripheral arteries to study in humans are the arteries of extremities. Although a reduction in leg vascular resistance in individuals with SCI has been reported in one study, 83 the majority of studies report the opposite, that is, leg vascular resistance, measured during supine rest, is increased following SCI. 35, [84] [85] [86] The mechanism(s) responsible for the increased leg vascular resistance do not appear to be related to loss of centrally mediated sympathetic tonic control, as graded infusions of phentalomine (competitive antagonist of a-adrenoceptors) during b-adrenoceptor blockade induced a similar degree of upper-leg vasodilation in SCI compared with AB, indicating that a-adrenergic tone is relatively well preserved in the legs of individuals with SCI. 84 Instead, increased vascular resistance may be accounted for by alterations in vasoconstrictor pathways. For example, sympathetic hypoactivity following high thoracic or cervical SCI causes a reduction in circulating levels of epinephrine and NE, 87 which may be compensated for by hypersensitivy to vasoconstrictor substances. Indeed, tetraplegics have an enhanced pressor response to intravenous NE infusions [88] [89] [90] and to phenylephrine (PE), an NE mimetic that is more specific to a-adrenoceptors. 88 Although such hypersensitivity may be explained partly by an impairment of the arterial baroreflex, 88 it still remains unclear in humans whether the enhanced pressor response actually results from post-synaptic hypersensitivity, as impaired re-uptake of NE may also account for such a response. There is also growing evidence that other vasoconstrictor pathways, such as angiotensin II 88, 91 and endothelin I, 85 may also contribute to the increased vascular resistance in the lower limbs of individuals with SCI.
Animal studies investigating hypersensitivity of a-adrenoceptors after SCI have reported contrasting results. In second-order mesenteric (resistance) arteries of SCI rats, studies investigating a-adrenoceptor hypersensitivity via direct in vitro arterial preparations have reported an enhanced pressor response to PE compared with shaminjured controls. 92 In the tail artery, a-adrenoceptor hypersensitivity appears to be present in the acute (2 weeks), but not chronic (8 weeks) phase post injury. 93 The mechanism underlying this potential hypersensitivity of the a-adrenoceptors appears to be of peripheral rather than central origin, as rats that have undergone sympathetic decentralization exhibit a similar a-adrenoceptor hypersensitivity (that is, transient, but not chronic) as SCI rats. 94 The peripheral mechanism responsible for the enhanced pressor response does not appear to be endothelial dysfunction, as acetylcholine (endothelium-dependent)-induced vasorelaxation is normal following T3 SCI in rodents. 16 Instead, others have suggested that impaired neuronal re-uptake of NE and PE, 92, 95 and/or increased reactivity of the vascular smooth muscle 93 may be responsible for the enhanced pressor response to PE. However, it is also likely that other explanations for such hypersensitivity must exist as PE is metabolized in the liver by phase I and phase II enzyme systems (mainly monoamine oxidase) and is, therefore, not a substrate for neuronal re-uptake.
The functional consequences of any potential adrenoceptor hypersensitivity are also still not clear, and there appears to be disconnects between the animal and human literature. In humans, there is a growing body of evidence that suggests that peripheral adrenoceptor hypersensitivity may be partly responsible for the development of AD in individuals with SCI. 89 For instance, it has been shown that individuals with high SCI exhibit a marked blood pressure response to bladder distension compared with individuals with low SCI or AB. 96 The pressor response to bladder distension was not associated with increased plasma NE, renin, aldosterone, vasopressin or arginine, suggesting such a response was due to adrenoceptor hypersensitivity. The same research group also studied the effect of prazosin (a selective a-adrenoceptor antagonist) in individuals with high SCI who experienced AD on a daily basis. 97 They reported a reduction in the frequency and severity of AD in those treated with prazosin, further implicating the role of adrenoceptor hyper-responsiveness in the development of AD. However, in animals with high thoracic SCI, it appears that aadrenoceptor hypersensitivity and enhanced severity of AD are not mutually exclusive. On the contrary, it has been reported that daily induction of a 30 min bout of AD via colorectal distension caused aadrenoceptor hypersensitivity, but this was accompanied by a less severe pressor response to a single bout of colorectal distension (that is, reduced severity of AD). 16 Thus, future studies are required to determine whether a-adrenoceptor hypersensitivity occurs after SCI and the potential effect of such hypersensitivity on the cardiovascular system.
Microvascular changes after SCI
Compared with conduit artery function, remarkably little is known about the microcirculation after SCI. Using a local heating protocol to examine NO-mediated vasodilation of the skin, it has been reported that cutaneous vascular conductance (CVC) below the injury is either impaired 98, 99 or preserved. 100 There is also evidence that CVC is reduced in the arms of paraplegic individuals. 99 Interestingly, the altered CVC in SCI does not seem to be a consequence of inactivity as an 8-week FES cycling intervention did not alter CVC in either the arms or the legs. 99 The lack of change in CVC with exercise is probably due to the small active muscle mass involved in FES cycling, which would be expected to impart little change in core body temperature and skin temperature. Furthermore, an increase in core body temperature in SCI is also associated with smaller changes in skin blood flow compared with uninjured individuals. 101 Hence, it is unlikely that FES cycling provided a sufficient change in skin blood flow to cause any chronic changes in CVC. The lack of exerciseinduced change in the microcirculation is in contrast to conduit arteries, which respond positively to exercise (see 'Deconditioninginduced alterations in blood vessels' below). Thus, it appears that vascular changes with exercise in SCI are not consistent among all vascular beds.
ABNORMAL BLOOD PRESSURE AND STRUCTURAL ALTERATIONS IN THE VASCULATURE
Data from AB hypertensive patients provide clear insight into changes within the small blood vessels that result from chronic elevations of arterial blood pressure. [102] [103] [104] It is now widely accepted that chronic constriction of the blood vessels, particularly at the level of the resistance vessels, results in locally damaging increases in blood flow velocity and turbulence that can increase shear stress, damage the endothelium and produce maladaptive remodeling of the vasculature. [105] [106] [107] Indeed, Rizzoni et al. 108 reported that such structural alterations in the small arteries represent the most potent predictor for CVD in the hypertensive population. Less is known about the effects of intermittent or episodic hypertension per se. It is the arterioles that provide the major site of resistance to blood flow in the circulation, and any repeated constriction at this level may cause a sustained hypertension and a chronic fixed pattern of narrowing in these arterioles. 109 In this regard, rodent studies have revealed that repeated episodes of blood vessel constriction stimulates arteriolar smooth muscle cell proliferation and hypertrophy, as well as connective tissue formation, eventually leading to increased arteriolar wall thickness, 110, 111 which is characteristic of the fixed hypertensive state. 104, 112 In the only study to examine the effect of episodic hypertension per se on vascular endothelial function in SCI, it was reported that 2 weeks of repetitively induced AD in rodents with T3 SCI exacerbates injury-induced hypersensitivity to PE in superior mesenteric arteries (Figure 3 ), but does not appear to alter endothelial function. 16 That study, however, only assessed hypersensitivity following a relatively short time span of induced AD; thus, the long-term effects of such blood pressure oscillations in SCI remain unknown. There are several lines of evidence from other pathological states that suggest chronic blood pressure oscillations damage the vascular endothelium. For example, animal models reveal that experimental alterations in arterial hemodynamics can produce endothelial damage. 113 Furthermore, numerous studies have demonstrated that preeclampsia, an intermittent hypertensive state that occurs for a short period of time in 4-5% of human pregnancies, is associated with both early and late vascular dysfunction. 114, 115 Specifically, endothelial function estimated by FMD is chronically impaired in preeclampsic vs non-preeclampsic females, 116 and the vascular smooth muscle of females with preeclampsia exhibits hypersensitivity to vasopressors such as angiotensin. 117 Such similarities between preeclampsia and SCI suggest that blood pressure oscillations may contribute to vascular dysfunction. However, to date this intriguing hypothesis is yet to be tested in humans with SCI and there is a lack of animal data demonstrating how spontaneously occurring AD, which is known to occur multiple times per day in animal models of SCI, 118 affects the vasculature.
DECONDITIONING-INDUCED ALTERATIONS IN VASCULATURE
A likely contributor to the vascular dysfunction exhibited by individuals with SCI is inactivity. A number of studies have investigated the effect of inactivity on arterial dynamics in AB individuals, and these have been reviewed elsewhere. 119, 120 Briefly, using horizontal bed rest as a model for inactivity, it has been reported that vessel diameter and blood flow are reduced, endothelial function is impaired and shear stress and peripheral resistance are increased. 82 It has also been shown that the structural alterations resulting from inactivity can be ameliorated with regular physical activity, 70 and that such changes occur within days or weeks of the onset of exercise. 71, 72 To understand how inactivity affects arterial dynamics in SCI, numerous studies have investigated arterial structure and function in response to a variety of exercise training interventions, of which hybrid exercise and FES cycle exercise have received the most attention. These studies have been reviewed previously 121 and will not be discussed further; however, a brief summary of these studies is warranted. Hybrid exercise, which incorporates upper body armcrank exercise with lower body FES, improves femoral artery function via increases in basal arterial blood flow, 122, 123 peak blood flow, 123 diameter, 122 and FMD. 122 Similarly, FES cycling alone has been demonstrated to increase femoral artery blood flow, 52, 86, 124 improve compliance in small arteries 125 and femoral arteries, 69 normalize femoral artery endothelial function, 69 reduce leg vascular resistance 86 and improve the femoral hyperemic blood flow response. 52 Unfortunately, many of those studies are limited by a small number of subjects and the lack of an appropriate control group (that is, lesion-matched SCI control group who do not undertake the exercise intervention). Despite these shortcomings, the dependency of any changes in arterial dynamics on exercise has been demonstrated by Thijjsen et al., 122 who showed that the improvements in vascular function following FES cycle training returned to baseline values within 1-6 weeks of exercise cessation (Figure 4) .
Improved vascular function in response to exercise is consistent with a number of other populations who exhibit an increased CVD risk. 61 In these populations, it appears likely that the exercise-induced improvement in vascular function is due to an increased shear stress and enhanced NO bioactivity. 126 To our knowledge, no study has investigated whether similar mechanisms underlie the exerciseinduced improvement in vascular function in people with SCI. Interestingly, data from other populations at risk of CVD has demonstrated that exercise-induced improvements in vascular function may be dose-dependent and represent a balance between oxidative stress and NO bioavailability. For instance, high-intensity exercise, which is associated with increased oxidative stress, may negate the potential increase in NO bioavailability that is observed with moderate-intensity exercise. 127 Given individuals with SCI exhibit an increased oxidative stress 128, 129 and systemic inflammation, 130 it is highly likely that any improvements in vascular function in SCI will be heavily dose-dependent. Thus, future studies should attempt to elucidate the mechanistic basis for vascular changes after SCI and the optimum type and dose of exercise required to elicit improvements in vascular function. To our knowledge, only two studies have investigated the effect of exercise on cardiovascular function in animals with SCI. Collins et al. 131 reported that acute (1 bout) treadmill exercise reduced the severity of AD induced via colorectal distension. Although those authors attributed this reduction in AD severity to an exerciseinduced reduction in a-adrenoceptor hypersensitivity, no measures of hypersensitivity were included in their experimental design; hence, the mechanistic basis for the acute reduction in AD severity could not be determined. In the only study to investigate the long-term effects of exercise training on cardiovascular function, Laird et al. 132 reported that 6 weeks (10 min per day, 5 Â a week) of treadmill training exacerbated the severity of AD, enhanced the renal pressor response to PE and increased calcitonin gene-related peptide immunoreactivity in lamina III/IV of the lumbar spinal cord, the latter of which suggests sprouting of small diameter spinal afferents that may contribute to the heightened AD severity. Exacerbation of AD and heightened vascular dysfunction after long-term exercise training in a rodent model of SCI appears to be at odds with the known beneficial effects of exercise on cardiovascular function in humans with SCI (see above). However, as only one study has investigated the vascular responses to long-term exercise training in rodents with SCI, future studies are urgently required to further our understanding of the potential effects of exercise in this population.
CONCLUSIONS
Individuals with SCI exhibit vascular dysfunction below the lesion that is characterized by a reduction in conduit artery diameter and blood flow, increased shear rate and leg vascular resistance, and adrenoceptor hyper-responsiveness. Although the mechanisms underlying vascular dysfunction following SCI remain to be elucidated, there is emerging evidence that blood pressure oscillations, such as those occurring in the large majority of individuals with SCI, could potentially exacerbate vascular dysfunction. Further to changes in the peripheral conduit and resistance vasculature, there is alarming evidence for central arterial stiffening in individuals with SCI. Such stiffening is likely to contribute to the early onset of CVD, which is currently the number one cause of mortality in the SCI population. Fortunately, it is likely that exercise provides a means by which vascular dysfunction can be ameliorated; however, the mechanistic basis by which exercise improves vascular function remains to be determined. Nevertheless, the evidence in human studies to date suggests that individuals with SCI should be encouraged to undertake regular exercise to reduce the secondary cardiovascular complications associated with SCI.
